Search results
Found 27 matches for
Science Museum’s Injecting Hope exhibition enters final week
Events News Vaccines, treatments, diagnostics & trials
2 May 2024
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
Researchers enrol record number of patients for landmark plague trial
Research news Vaccines, treatments, diagnostics & trials
26 April 2024
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Oxford hosts Belgian vaccine experts
News Vaccines, treatments, diagnostics & trials
28 March 2024
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
FCDO Minister meets with University of Oxford’s vaccine researchers
Partner news Vaccines, treatments, diagnostics & trials
26 January 2024
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
Vaccine trial for deadly Nipah virus launched
Nipah virus Research news Vaccines, treatments, diagnostics & trials
11 January 2024
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
New partnership aims to advance vaccine against MERS coronavirus
Partner news Vaccines, treatments, diagnostics & trials
21 December 2023
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats
Partner news Vaccines, treatments, diagnostics & trials
12 December 2023
New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.
Oxford welcomes global pandemic experts for focus on 100 Days Mission
Partner news Vaccines, treatments, diagnostics & trials
2 November 2023
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
Research news Vaccines, treatments, diagnostics & trials
2 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
World-leading RECOVERY trial expands to investigate treatments for influenza
Research news Vaccines, treatments, diagnostics & trials
30 October 2023
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Conference brings together clinical researchers to explore lessons from COVID-19 for global research collaboration
Events News Vaccines, treatments, diagnostics & trials
16 October 2023
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
Global collaboration to develop next-generation COVID-19 and flu vaccines
News Research news Vaccines, treatments, diagnostics & trials
10 October 2023
The University of Oxford has launched a new global vaccine collaboration, backed by £8 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
News Research news Vaccines, treatments, diagnostics & trials
18 September 2023
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched
News Research news Vaccines, treatments, diagnostics & trials
11 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
CEPI and University of Oxford to accelerate vaccine development against Disease X
News Research news Vaccines, treatments, diagnostics & trials
30 August 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast
News Vaccines, treatments, diagnostics & trials
28 April 2023
Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
£12 million investment for Future Vaccines Manufacturing Hub
News Research news Vaccines, treatments, diagnostics & trials
11 April 2023
A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
Why diversity matters in vaccine science
News Vaccines, treatments, diagnostics & trials
10 February 2023
Professor Teresa Lambe sets out her advice for young scientists to mark the International Day of Women and Girls in Science.
Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists
Awards Research news Vaccines, treatments, diagnostics & trials
9 December 2022
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
Oxford's Ebola vaccine recommended for deployment against Uganda outbreak
News Research news Vaccines, treatments, diagnostics & trials
22 November 2022
A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.